Tag: antimicrobial resistance
-
Antimicrobial resistance in surface waters: Europe-wide monitoring for health risk data
Why monitor antimicrobial resistance in surface waters across Europe? Natural environments can act as reservoirs for resistant microorganisms and for antibiotic resistance genes. Surface waters—rivers, lakes, and coastal zones—are dynamic interfaces where human activities, wastewater inputs, and natural microbial communities intersect. Monitoring antimicrobial resistance (AMR) in these waters provides critical data on the presence and…
-
Europe’s Surface Waters: A Unified Monitoring Plan to Track Antimicrobial Resistance
Why Europe Needs a Pan-Continental AMR Water Monitoring System Antimicrobial resistance (AMR) poses a growing threat to public health, and natural environments like rivers, lakes, and coastal waters can host resistant microorganisms. Europe-wide monitoring of AMR in surface waters offers a path to better data on health risks, more informed policy decisions, and swifter responses…
-
Europe-wide Monitoring of Antimicrobial Resistance in Surface Waters: A Path to Safer Health
Why Surface Waters Matter for Antimicrobial Resistance Antimicrobial resistance (AMR) is not confined to clinics. Natural environments, including rivers, lakes, and coastal waters, can act as reservoirs where resistant microorganisms thrive and exchange resistance genes. These genes can transfer between bacteria through horizontal gene transfer, potentially spreading resistance to pathogens that affect humans, animals, and…
-
EMA ETF Improves Scientific Advice for Medicines and Vaccines Tackling Public Health Threats
Background: A New Era for Public Health Medicines The European Medicines Agency’s Emergency Task Force (ETF) is reforming how it provides scientific advice to developers working on medicines and vaccines for urgent public health threats. This initiative aims to streamline the path from early development to clinical evidence, with a particular focus on antimicrobial resistance…
-
EMA ETF Refines Scientific Advice for Antimicrobial Resistance Medicines and Public Health Threats
Enhancing Guidance for Medicines in Public Health Emergencies The European Medicines Agency’s (EMA) Emergency Task Force (ETF) is upgrading its approach to providing scientific advice for the most promising medicines and vaccines in development to combat public health threats. This evolution focuses on ensuring that life-saving therapies are developed with robust regulatory input, especially in…
-
Improved Scientific Advice for Medicines Tackling Public Health Threats, Including Antimicrobial Resistance
Raising the Bar for Medicines and Vaccines against Public Health Threats Public health threats evolve rapidly, from novel pathogens to the growing challenge of antimicrobial resistance (AMR). In response, the European Medicines Agency’s Emergency Task Force (ETF) is refining its approach to provide higher-quality, earlier scientific advice for medicines and vaccines under development. The aim…
-
Superbug Outbreak in Auckland and Christchurch Hospitals: What Health NZ Is Saying
Overview: A Growing Health Challenge Health NZ has confirmed a concerning outbreak of a superbug in Auckland and Christchurch hospitals. The situation highlights a broader public health issue: antimicrobial resistance (AMR). While specific organisms and transmission details are still under investigation, officials say one of the strains identified in Christchurch has been linked to an…
-
Superbug Outbreak: Auckland and Christchurch Hospitals Under Scrutiny by Health NZ
Overview: A Growing Hospital-Linked Superbug Issue Health New Zealand (Health NZ) has reported a cluster of antimicrobial-resistant (AMR) infections in hospitals across Auckland and Christchurch. The situation, described by health officials as serious but controllable with rapid action, underscores the ongoing threats posed by so-called superbugs in healthcare settings. One of the strains identified in…
-
Superbug Outbreak Ties Auckland and Christchurch Hospitals, Health NZ Warns
Overview: A Linked Outbreak Across Two Cities health authorities in New Zealand say a superbug outbreak has surfaced in Auckland and Christchurch hospitals, with one Christchurch strain linked to an Auckland cluster. The development underscores the ongoing challenge of antimicrobial resistance (AMR) in healthcare settings and the importance of rapid detection, coordinated response, and strict…
-
Antibiotic Found Hiding in Plain Sight Could Treat Dangerous Infections, Early Study Finds
Unexpected breakthrough: a new antibiotic class emerges In a surprising turn for antimicrobial research, scientists have identified the first compound of a promising new class of antibiotics. The discovery came not from a targeted search for drugs but from careful analysis of existing compounds and their interactions with stubborn, drug-resistant bacteria. While still early, the…